You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
凱普生物(300639.SZ):新冠病毒檢測產品通過巴西ANVISA認證
格隆匯 04-12 18:16

格隆匯4月12日丨凱普生物(300639.SZ)公佈,公司全資子公司潮州凱普生物化學有限公司自主研發的新型冠狀病毒核酸檢測試劑盒近日取得由ANVISA(巴西國家衞生監督局)簽發的認證證書。

新型冠狀病毒的核酸檢測是新型冠狀病毒肺炎感染確診的重要手段之一,新型冠狀病毒核酸檢測試劑盒是目前進行體外定性檢測新型冠狀病毒感染的肺炎疑似病例和其他需要進行新型冠狀病毒感染鑑別診斷者的主要方法。公司研發的新型冠狀病毒核酸檢測試劑盒以採樣便捷、檢測通量大、效率高、性價比高等特點,適合在疫情嚴重或正在蔓延的國家和地區開展大規模篩查,為疫情防控提供可靠診斷依據。

此前,公司上述產品已取得歐盟CE認證,申請列入世界衞生組織(WHO)應急使用清單(EUL)已獲受理,目前在向國家藥品監督管理局進行註冊申報。

此次公司產品通過ANVISA認證,取得巴西市場的准入資格,是國際市場對公司產品品質的認可,有利於進一步提升公司的國際競爭力,助力國際新型冠狀病毒感染的肺炎疫情防控工作。上述產品最終能否在巴西市場開展銷售業務取決於公司產品在國內的註冊情況;實際銷售情況取決於新型冠狀病毒感染的肺炎疫情防控涉及的檢測需求,公司目前尚無法預測其對公司未來業績的影響,敬請投資者注意投資風險。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account